MMWR

MMWR: Rapid Scale-up of an Antiretroviral Therapy Program Before and During the COVID-19 Pandemic

Apr 01, 2021 | Julia Zigman

A new Morbidity and Mortality Weekly Report (MMWR) from CDC outlines how comprehensive, data-guided, locally adapted interventions and incident command structures can help increase and retain the number of persons with HIV infection who receive ART, reducing HIV-related morbidity and mortality as well as decreasing HIV transmission.

Through the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), CDC launched an 18-month antiretroviral therapy (ART) Surge program in nine Nigerian states in April 2019, including implementation of incident command structures to manage operations. The Surge program established consortiums of public and non-governmental stakeholders which, partnered with high-level engagement by the U.S. Embassy and Consulate as well as broad data sharing with involved partners, increased local engagement and regular program evaluation. Through this program, the weekly number of persons with newly identified HIV infection who initiated ART increased approximately eightfold, from May 4, 2019, to September 26, 2020.

Read about how the Surge program adapted during the COVID-19 pandemic to increase ART initiation and retention in the CDC report here: Rapid Scale-up of an Antiretroviral Therapy Program Before and During the COVID-19 Pandemic — Nine States, Nigeria, March 31, 2019–September 30, 2020


NACCHO logo small version02 square N pms321 Invert

About Julia Zigman

Pronouns: she/her

Julia Zigman is a Program Analyst on the NACCHO HIV, STI, & Viral Hepatitis team. Julia focuses primarily on NACCHO’s Ending the HIV Epidemic portfolio and is a lead staff member for the HIV, STI, and Viral Hepatitis Workgroup. Learn more about these programs here.

More posts by Julia Zigman

Related Posts

  • Tools & Resources
  • HIV, STI, & Viral Hepatitis
  • Recommendations

Providing HIV Care and Client Services During...

HRSA’s HIV/AIDS Bureau has made available a detailed FAQ guide for Ryan White...

Mar 24, 2020 | Kim Rodgers

Providing HIV Care and Client Services During...

KFF logo
  • HIV, STI, & Viral Hepatitis

Delivering HIV Care and Prevention in the COVID Era: A...

To better understand the pandemic’s impact on HIV, KFF surveyed the nation’s...

Jan 06, 2021 | Shalesha Majors

Delivering HIV Care and Prevention in the COVID Era: A...

Care continuum banner v1
  • HIV, STI, & Viral Hepatitis
  • Research & Reports

Article: Impact of COVID-19 on CBOs and HIV Continuum of...

A new article published in AIDS and Behavior highlights the impact of COVID-19...

May 20, 2020 | Kat Kelley

Article: Impact of COVID-19 on CBOs and HIV Continuum of...

  • COVID-19
  • HIV, STI, & Viral Hepatitis

HIV Care and Coronavirus (COVID-19): Info and HHS/CDC...

TheBodyPro has developed a repository of information about the intersection of...

Jul 29, 2020 | Julia Zigman

HIV Care and Coronavirus (COVID-19): Info and HHS/CDC...

HIV COVID
  • COVID-19
  • HIV, STI, & Viral Hepatitis

Big Ideas in Brief on HIV Telehealth and Supporting HIV...

Two new one-pagers are available from the O’Neill Institute for National and...

Feb 18, 2021 | Julia Zigman

Big Ideas in Brief on HIV Telehealth and Supporting HIV...

HIV COVID
  • COVID-19
  • HIV, STI, & Viral Hepatitis

COVID-19: Considerations for People with HIV

Updated resource discussing clinical and public health considerations related...

Jan 06, 2021 | Julia Zigman

COVID-19: Considerations for People with HIV

HIV COVID
  • COVID-19
  • HIV, STI, & Viral Hepatitis

Study: Poorer COVID-19 Outcomes Among Persons Living...

Persons living with an HIV diagnosis experienced poorer COVID-related outcomes...

Feb 04, 2021 | Julia Zigman

Study: Poorer COVID-19 Outcomes Among Persons Living...

Back to Top